<VariationArchive VariationID="2422328" VariationName="NC_000007.13:g.(?_143013350)_(143018251_?)del" VariationType="Deletion" Accession="VCV002422328" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1942362" VariationID="2422328">
      <GeneList>
        <Gene Symbol="CLCN1" FullName="chloride voltage-gated channel 1" GeneID="1180" HGNC_ID="HGNC:2019" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q34</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="143316111" stop="143352083" display_start="143316111" display_stop="143352083" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="143013218" stop="143049096" display_start="143013218" display_stop="143049096" Strand="+" />
          </Location>
          <OMIM>118425</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000007.13:g.(?_143013350)_(143018251_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q34</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" innerStart="143013350" innerStop="143018251" display_start="143013350" display_stop="143018251" variantLength="4902" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.(?_143013350)_(143018251_?)del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.(?_143013350)_(143018251_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000007.13:g.(?_143013350)_(143018251_?)del AND multiple conditions" Accession="RCV003119277" Version="4">
        <ClassifiedConditionList TraitSetID="10487">
          <ClassifiedCondition DB="MedGen" ID="C2936781">Congenital myotonia, autosomal dominant form</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0751360">Congenital myotonia, autosomal recessive form</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-19" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16199547</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17932099</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22094069</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23739125</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26502825</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="10487" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3015" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital myotonia, autosomal recessive form</ElementValue>
                <XRef ID="Myotonia+congenita+autosomal+recessive/5074" DB="Genetic Alliance" />
                <XRef ID="20305008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myotonia congenita autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Becker disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myotonia generalized</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Becker's disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Becker Generalized Myotonia</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Myotonia congenita is characterized by muscle stiffness present from childhood; all striated muscle groups including the extrinsic eye muscles, facial muscles, and tongue may be involved. Stiffness is relieved by repeated contractions of the muscle (the "warm-up" phenomenon). Muscles are usually hypertrophic. Whereas autosomal recessive (AR) myotonia congenita is often associated with more severe manifestations (such as progressive minor distal weakness and attacks of transient weakness brought on by movement after rest), autosomal dominant (AD) myotonia congenita is not. The age of onset varies: in AD myotonia congenita onset is usually in infancy or early childhood; in AR myotonia congenita the average age of onset is slightly older. In both AR and AD myotonia congenita onset may be as late as the third or fourth decade of life.</Attribute>
                <XRef ID="NBK1355" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="844" />
                <XRef ID="844" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301529</ID>
                <ID Source="BookShelf">NBK1355</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="614" DB="Orphanet" />
              <XRef ID="C0751360" DB="MedGen" />
              <XRef ID="MONDO:0009715" DB="MONDO" />
              <XRef Type="MIM" ID="255700" DB="OMIM" />
            </Trait>
            <Trait ID="5605" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Myotonia congenita autosomal dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thomsen disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thomsen's disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital myotonia, autosomal dominant form</ElementValue>
                <XRef ID="Myotonia+congenita+autosomal+dominant/5073" DB="Genetic Alliance" />
                <XRef ID="57938005" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">THD</ElementValue>
                <XRef Type="MIM" ID="160800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Myotonia congenita is characterized by muscle stiffness present from childhood; all striated muscle groups including the extrinsic eye muscles, facial muscles, and tongue may be involved. Stiffness is relieved by repeated contractions of the muscle (the "warm-up" phenomenon). Muscles are usually hypertrophic. Whereas autosomal recessive (AR) myotonia congenita is often associated with more severe manifestations (such as progressive minor distal weakness and attacks of transient weakness brought on by movement after rest), autosomal dominant (AD) myotonia congenita is not. The age of onset varies: in AD myotonia congenita onset is usually in infancy or early childhood; in AR myotonia congenita the average age of onset is slightly older. In both AR and AD myotonia congenita onset may be as late as the third or fourth decade of life.</Attribute>
                <XRef ID="NBK1355" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6176" />
                <XRef ID="6176" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301529</ID>
                <ID Source="BookShelf">NBK1355</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="614" DB="Orphanet" />
              <XRef ID="C2936781" DB="MedGen" />
              <XRef ID="MONDO:0008055" DB="MONDO" />
              <XRef Type="MIM" ID="160800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7071097" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_000083.2_7_Partial deletion (exons 1-3)_143013349_143018251|MedGen:C0751360;C2936781" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003790243" DateUpdated="2024-06-09" DateCreated="2023-02-13" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16199547</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17932099</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22094069</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23739125</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22094069</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26502825</ID>
          </Citation>
          <Comment>This variant results in the deletion of exons 2-3 and part of exon 1 (c.45_434-207del) of the CLCN1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in CLCN1 are known to be pathogenic (PMID: 17932099, 22094069, 23739125). This variant has not been reported in the literature in individuals affected with CLCN1-related conditions. ClinVar contains an entry for this variant (Variation ID: 580190). This variant disrupts a region of the CLCN1 protein in which other variant(s) (p.Tyr137Asp) have been determined to be pathogenic (PMID: 22094069, 26502825). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CLCN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.(?_143013350)_(143018251_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751360" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2936781" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7071097" TraitType="Disease" MappingType="XRef" MappingValue="C2936781" MappingRef="MedGen">
        <MedGen CUI="C2936781" Name="Congenital myotonia, autosomal dominant form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7071097" TraitType="Disease" MappingType="XRef" MappingValue="C0751360" MappingRef="MedGen">
        <MedGen CUI="C0751360" Name="Congenital myotonia, autosomal recessive form" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

